BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 36890219)

  • 1. A comprehensive analysis of PANoptosome to prognosis and immunotherapy response in pan-cancer.
    Zhuang L; Sun Q; Huang S; Hu L; Chen Q
    Sci Rep; 2023 Mar; 13(1):3877. PubMed ID: 36890219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PANoptosis subtypes predict prognosis and immune efficacy in gastric cancer.
    Liu Z; Sun L; Peng X; Zhu J; Wu C; Zhu W; Huang C; Zhu Z
    Apoptosis; 2024 Jun; 29(5-6):799-815. PubMed ID: 38347337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of PANoptosis patterns predicts survival and immunotherapy response in gastric cancer.
    Pan H; Pan J; Li P; Gao J
    Clin Immunol; 2022 May; 238():109019. PubMed ID: 35470064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Subtypes Based on PANoptosis Genes and Characteristics of Immune Infiltration in Cutaneous Melanoma.
    Zhong L; Qian W; Gong W; Zhu L; Wang X
    Cell Mol Biol (Noisy-le-grand); 2023 Aug; 69(8):1-8. PubMed ID: 37715443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting Prognosis and Immunotherapy Response in Multiple Cancers Based on the Association of PANoptosis-Related Genes with Tumor Heterogeneity.
    Wang Y; Zhang B; Zhang Z; Ge J; Xu L; Mao J; Zhou X; Mao L; Xu Q; Sang M
    Genes (Basel); 2023 Oct; 14(11):. PubMed ID: 38002938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The PANoptosis-related signature indicates the prognosis and tumor immune infiltration features of gliomas.
    Song J; Xu Z; Fan Q; Sun Y; Lin X
    Front Mol Neurosci; 2023; 16():1198713. PubMed ID: 37501725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The PANoptosome: A Deadly Protein Complex Driving Pyroptosis, Apoptosis, and Necroptosis (PANoptosis).
    Samir P; Malireddi RKS; Kanneganti TD
    Front Cell Infect Microbiol; 2020; 10():238. PubMed ID: 32582562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the PANoptosome: A Molecular Platform Triggering Pyroptosis, Apoptosis, and Necroptosis (PANoptosis).
    Christgen S; Zheng M; Kesavardhana S; Karki R; Malireddi RKS; Banoth B; Place DE; Briard B; Sharma BR; Tuladhar S; Samir P; Burton A; Kanneganti TD
    Front Cell Infect Microbiol; 2020; 10():237. PubMed ID: 32547960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of PANoptosis signature: Novel target discovery for prostate cancer immunotherapy.
    Yi X; Li J; Zheng X; Xu H; Liao D; Zhang T; Wei Q; Li H; Peng J; Ai J
    Mol Ther Nucleic Acids; 2023 Sep; 33():376-390. PubMed ID: 37547288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. It's All in the PAN: Crosstalk, Plasticity, Redundancies, Switches, and Interconnectedness Encompassed by PANoptosis Underlying the Totality of Cell Death-Associated Biological Effects.
    Gullett JM; Tweedell RE; Kanneganti TD
    Cells; 2022 Apr; 11(9):. PubMed ID: 35563804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of the panoptosis-related gene model and characterization of tumor microenvironment infiltration in hepatocellular carcinoma.
    Shi X; Gao X; Liu W; Tang X; Liu J; Pan D; Duan X; Jin Y; Ren W; Yang L; Liu W
    Oncol Res; 2023; 31(4):569-590. PubMed ID: 37415742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PANoptosis-based molecular clustering and prognostic signature predicts patient survival and immune landscape in colon cancer.
    Wang X; Sun R; Chan S; Meng L; Xu Y; Zuo X; Wang Z; Hu X; Han Q; Dai L; Bai T; Yu Z; Wang M; Yang W; Zhang H; Chen W
    Front Genet; 2022; 13():955355. PubMed ID: 36186438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring PANoptosis in breast cancer based on scRNA-seq and bulk-seq.
    He P; Ma Y; Wu Y; Zhou Q; Du H
    Front Endocrinol (Lausanne); 2023; 14():1164930. PubMed ID: 37455906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PANoptosis-related molecular subtype and prognostic model associated with the immune microenvironment and individualized therapy in pancreatic cancer.
    Zhang B; Huang B; Zhang X; Li S; Zhu J; Chen X; Song H; Shang D
    Front Oncol; 2023; 13():1217654. PubMed ID: 37519797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PANoptosis-related prognostic signature predicts overall survival of cutaneous melanoma and provides insights into immune infiltration landscape.
    Wang W; Zhou Q; Lan L; Xu X
    Sci Rep; 2023 May; 13(1):8449. PubMed ID: 37231081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PANoptosis: Mechanisms, biology, and role in disease.
    Sun X; Yang Y; Meng X; Li J; Liu X; Liu H
    Immunol Rev; 2024 Jan; 321(1):246-262. PubMed ID: 37823450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current evidence and therapeutic implication of PANoptosis in cancer.
    Ocansey DKW; Qian F; Cai P; Ocansey S; Amoah S; Qian Y; Mao F
    Theranostics; 2024; 14(2):640-661. PubMed ID: 38169587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From pyroptosis, apoptosis and necroptosis to PANoptosis: A mechanistic compendium of programmed cell death pathways.
    Wang Y; Kanneganti TD
    Comput Struct Biotechnol J; 2021; 19():4641-4657. PubMed ID: 34504660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PANoptosis: Emerging mechanisms and disease implications.
    Qi Z; Zhu L; Wang K; Wang N
    Life Sci; 2023 Nov; 333():122158. PubMed ID: 37806654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PANoptosis in cancer, the triangle of cell death.
    Cai H; Lv M; Wang T
    Cancer Med; 2023 Dec; 12(24):22206-22223. PubMed ID: 38069556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.